Adma Biologics (ADMA) Non Operating Income (2011 - 2025)
Adma Biologics (ADMA) reported Non Operating Income of -$8.6 million for Q4 2025, down 190.77% on a YoY basis from $9.5 million in Q4 2024, and down 40814.29% quarter-over-quarter from -$21000.0 in Q3 2025.
Adma Biologics (ADMA) Non Operating Income (2011 - 2025) Analysis & Trends
Adma Biologics has reported Non Operating Income for 13 years, with the latest figure at -$8.6 million in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income fell 190.77% year-over-year to -$8.6 million; the trailing twelve-month figure through Dec 2025 stood at -$8.8 million (down 432.77% YoY), and the FY2025 full-year result was -$8.8 million, down 4452.85% from the prior year.
- Non Operating Income for Q4 2025 stood at -$8.6 million, down from -$21000.0 in the prior quarter.
- The five-year high for Non Operating Income was $9.5 million in Q4 2024, with the low at -$49.7 million in Q4 2023.
- Historically, Non Operating Income has averaged -$5.4 million across 5 years, with a median of -$3.3 million in 2021.
- The largest YoY upside for Non Operating Income was 119.05% in 2024 against a maximum downside of 25669.23% in 2024.
- Adma Biologics' Non Operating Income stood at -$13.2 million in 2021, then surged by 53.12% to -$6.2 million in 2022, then tumbled by 704.84% to -$49.7 million in 2023, then jumped by 119.05% to $9.5 million in 2024, then plunged by 190.77% to -$8.6 million in 2025.
- The last three Non Operating Income figures came in at -$8.6 million (Q4 2025), -$21000.0 (Q3 2025), and -$108000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | -8.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.59 Mn |
| Sep 30, 2025 | -21,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Mar 31, 2025 | -64,000.00 |
| Dec 31, 2024 | 9.47 Mn |
| Sep 30, 2024 | -56,000.00 |
| Jun 30, 2024 | -3.35 Mn |
| Mar 31, 2024 | -3.42 Mn |
| Dec 31, 2023 | -49.69 Mn |
| Sep 30, 2023 | -6.12 Mn |
| Jun 30, 2023 | -13,000.00 |
| Mar 31, 2023 | -27,000.00 |
| Dec 31, 2022 | -6.17 Mn |
| Sep 30, 2022 | -5.58 Mn |
| Jun 30, 2022 | -4.59 Mn |
| Mar 31, 2022 | -10.19 Mn |
| Dec 31, 2021 | -13.17 Mn |
| Sep 30, 2021 | -3.28 Mn |
| Jun 30, 2021 | -3.32 Mn |
| Mar 31, 2021 | -42,001.00 |